Research
-
Elucidating molecular and biophysical mechanisms that regulate hemostasis and thrombosis with emphasis on the development of humanized animal models, new POC technologies, novel pharmacologic agents, and clinical trials focused on critically ill neonates.
- Cell signaling with emphasis on the role of class I PI3Ks in regulating adaptive and innate immune responses.
- Development and testing of novel blood products for transfusion
PATENTS:
US9686971. Methods for testing anti-thrombotic agents.
US11459306. Compounds, compositions, and methods for treating T-cell acute lymphoblastic leukemia.
US11260071. Method of preventing systemic-to-pulmonary-artery shunt thrombosis.
PubMed bibliography:
https://www.ncbi.nlm.nih.gov/myncbi/thomas.diacovo.1/bibliography/public/
